Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

ctDNA From Blood Equals or Bests Tissue-Based Tests in Triple Negative Breast Cancer

Summary by Inside Precision Medicine
A blood-based ctDNA test was just as accurate as using tumor tissue for molecular residual disease detection in triple negative breast cancer, a new U.K. study shows. This finding provides more evidence that ctDNA has wide application in cancer treatment guidance.

1 Articles

Inside Precision MedicineInside Precision Medicine
Center

ctDNA From Blood Equals or Bests Tissue-Based Tests in Triple Negative Breast Cancer

A blood-based ctDNA test was just as accurate as using tumor tissue for molecular residual disease detection in triple negative breast cancer, a new U.K. study shows. This finding provides more evidence that ctDNA has wide application in cancer treatment guidance.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Inside Precision Medicine broke the news on Wednesday, August 19, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Breast Cancer icon

Breast Cancer

London, England icon

London, England

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal